Annovis Bio, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
VANGUARD GROUP INC | 11/13/2024 | 380,255 | $3.06 M | 5.23% | 2.93% |
LMR PARTNERS LLP | 11/07/2024 | 272,600 | $2.20 M | -52.35% | 2.10% |
CITADEL ADVISORS LLC | 11/14/2024 | 264,600 | $2.13 M | 91.88% | 2.04% |
ALTIUM CAPITAL MANAGEMENT LP | 11/14/2024 | 236,400 | $1.91 M | 52.22% | 1.82% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2024 | 185,000 | $1.49 M | -44.76% | 1.43% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2024 | 130,600 | $1.05 M | -60.70% | 1.01% |
CITADEL ADVISORS LLC | 11/14/2024 | 102,692 | $827,698 | 100.00% | 0.79% |
BLACKROCK FUNDING, INC. /DE | 11/13/2024 | 101,495 | $818,051 | 100.00% | 0.78% |
GEODE CAPITAL MANAGEMENT, LLC | 11/12/2024 | 99,114 | $798,989 | 30.01% | 0.76% |
GROUP ONE TRADING, L.P. | 11/14/2024 | 52,767 | $425,302 | 100.00% | 0.41% |
QUEST PARTNERS LLC | 11/07/2024 | 46,002 | $370,776 | 100.00% | 0.35% |
WESCOTT FINANCIAL ADVISORY GROUP, LLC | 11/12/2024 | 41,607 | $335,352 | 0.00% | 0.32% |
STATE STREET CORP | 11/14/2024 | 36,035 | $290,442 | 23.68% | 0.28% |
STERLING INVESTMENT ADVISORS, LTD. | 10/24/2024 | 34,474 | $277,860 | 2.99% | 0.27% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2024 | 31,520 | $254,051 | 100.00% | 0.24% |
MERIT FINANCIAL GROUP, LLC | 10/17/2024 | 26,700 | $215,202 | 23.04% | 0.21% |
D. E. SHAW & CO., INC. | 11/14/2024 | 24,410 | $196,745 | 100.00% | 0.19% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 11/14/2024 | 22,100 | $178,126 | 0.00% | 0.17% |
JANE STREET GROUP, LLC | 11/15/2024 | 20,206 | $162,860 | 99.60% | 0.16% |
SPEARS ABACUS ADVISORS LLC | 11/12/2024 | 20,000 | $161,200 | 33.33% | 0.15% |
BANK OF NEW YORK MELLON CORP | 11/12/2024 | 19,059 | $153,616 | 0.00% | 0.15% |
CITADEL ADVISORS LLC | 11/14/2024 | 17,800 | $143,468 | -88.33% | 0.14% |
SQUAREPOINT OPS LLC | 11/14/2024 | 17,200 | $138,632 | -31.20% | 0.13% |
GREENWICH WEALTH MANAGEMENT LLC | 10/29/2024 | 16,475 | $133,000 | 9.29% | 0.13% |
JANE STREET GROUP, LLC | 11/15/2024 | 13,900 | $112,034 | 100.00% | 0.11% |
BANK OF MONTREAL /CAN/ | 11/13/2024 | 13,500 | $109,350 | 100.00% | 0.10% |
LOKKEN INVESTMENT GROUP LLC | 11/12/2024 | 12,235 | $98,614 | 0.00% | 0.09% |
WEALTHSPIRE ADVISORS, LLC | 11/13/2024 | 10,000 | $80,600 | 0.00% | 0.08% |
WELLS FARGO & COMPANY/MN | 11/13/2024 | 9,746 | $78,556 | 11.42% | 0.08% |
BRYN MAWR TRUST CO | 11/25/2024 | 9,393 | $75,708 | 100.00% | 0.07% |
SIMPLEX TRADING, LLC | 11/08/2024 | 8,605 | $69,000 | 100.00% | 0.07% |
BANK OF AMERICA CORP /DE/ | 11/14/2024 | 6,080 | $49,005 | 20.04% | 0.05% |
JPMORGAN CHASE & CO | 11/08/2024 | 3,800 | $30,628 | 100.00% | 0.03% |
TOWER RESEARCH CAPITAL LLC (TRC) | 11/14/2024 | 3,087 | $24,881 | -54.99% | 0.02% |
UBS GROUP AG | 11/14/2024 | 1,847 | $14,887 | -85.78% | 0.01% |
MORGAN STANLEY | 11/14/2024 | 1,350 | $10,881 | -75.45% | 0.01% |
ADVISOR GROUP HOLDINGS, INC. | 11/13/2024 | 1,200 | $9,672 | -5.88% | 0.01% |
BOKF, NA | 11/14/2024 | 555 | $4,451 | 100.00% | 0.00% |
RHUMBLINE ADVISERS | 11/12/2024 | 350 | $2,821 | 100.00% | 0.00% |
GAME PLAN FINANCIAL ADVISORS, LLC | 10/15/2024 | 200 | $1,612 | 0.00% | 0.00% |
WR WEALTH PLANNERS, LLC | 10/17/2024 | 150 | $1,209 | 0.00% | 0.00% |
EVERSOURCE WEALTH ADVISORS, LLC | 11/08/2024 | 83 | $669 | 0.00% | 0.00% |
FMR LLC | 11/13/2024 | 0 | $0 | -100.00% | 0.00% |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 11/14/2024 | 0 | $0 | -100.00% | 0.00% |
GTS SECURITIES LLC | 11/13/2024 | 0 | $0 | -100.00% | 0.00% |
HAP TRADING, LLC | 11/12/2024 | 0 | $0 | -100.00% | 0.00% |
MODERA WEALTH MANAGEMENT, LLC | 10/24/2024 | 0 | $0 | -100.00% | 0.00% |
BOOTHBAY FUND MANAGEMENT, LLC | 11/14/2024 | 0 | $0 | -100.00% | 0.00% |
UBS GROUP AG | 11/14/2024 | 0 | $0 | -100.00% | 0.00% |
BELVEDERE TRADING LLC | 11/01/2024 | 0 | $0 | -100.00% | 0.00% |
Annovis Bio, Inc.institutional Ownership - FAQ's
During the previous two years, 45 institutional investors and hedge funds held shares of Annovis Bio, Inc.. The most heavily invested institutionals were:
VANGUARD GROUP INC: 380,255
CITADEL ADVISORS LLC: 102,692
BlackRock Funding, Inc. /DE: 101,495
GEODE CAPITAL MANAGEMENT, LLC: 99,114
GROUP ONE TRADING, L.P.: 52,767
Quest Partners LLC: 46,002
9.09% of Annovis Bio, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 1.32 M shares in the last 24 months. This purchase volume represents approximately $6.64 M in transactions.